Taiwan · Delayed Price · Currency is TWD Orient EuroPharma Statistics
Total Valuation
TPEX:4120 has a market cap or net worth of TWD 4.00 billion. The enterprise value is 6.27 billion.
| Market Cap | 4.00B |
| Enterprise Value | 6.27B |
Important Dates
The next estimated earnings date is Tuesday, May 12, 2026.
| Earnings Date | May 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:4120 has 86.75 million shares outstanding. The number of shares has increased by 0.01% in one year.
| Current Share Class | 86.75M |
| Shares Outstanding | 86.75M |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | 14.72% |
| Owned by Institutions (%) | 0.31% |
| Float | 31.45M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.87 |
| PB Ratio | 0.54 |
| P/TBV Ratio | 0.64 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -11.05 |
| EV / Sales | 1.36 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -13.46 |
Financial Position
The company has a current ratio of 1.47, with a Debt / Equity ratio of 0.45.
| Current Ratio | 1.47 |
| Quick Ratio | 1.02 |
| Debt / Equity | 0.45 |
| Debt / EBITDA | n/a |
| Debt / FCF | -7.14 |
| Interest Coverage | -4.19 |
Financial Efficiency
Return on equity (ROE) is -7.29% and return on invested capital (ROIC) is -3.60%.
| Return on Equity (ROE) | -7.29% |
| Return on Assets (ROA) | -1.63% |
| Return on Invested Capital (ROIC) | -3.60% |
| Return on Capital Employed (ROCE) | -3.34% |
| Weighted Average Cost of Capital (WACC) | 3.77% |
| Revenue Per Employee | 13.55M |
| Profits Per Employee | -1.67M |
| Employee Count | 339 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 2.19 |
Taxes
In the past 12 months, TPEX:4120 has paid 207.16 million in taxes.
| Income Tax | 207.16M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -8.17% in the last 52 weeks. The beta is 0.22, so TPEX:4120's price volatility has been lower than the market average.
| Beta (5Y) | 0.22 |
| 52-Week Price Change | -8.17% |
| 50-Day Moving Average | 44.85 |
| 200-Day Moving Average | 48.55 |
| Relative Strength Index (RSI) | 53.48 |
| Average Volume (20 Days) | 47,642 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:4120 had revenue of TWD 4.60 billion and -567.39 million in losses. Loss per share was -6.54.
| Revenue | 4.60B |
| Gross Profit | 2.24B |
| Operating Income | -310.54M |
| Pretax Income | -273.03M |
| Net Income | -567.39M |
| EBITDA | -112.75M |
| EBIT | -310.54M |
| Loss Per Share | -6.54 |
Balance Sheet
The company has 2.12 billion in cash and 3.33 billion in debt, with a net cash position of -1.20 billion or -13.88 per share.
| Cash & Cash Equivalents | 2.12B |
| Total Debt | 3.33B |
| Net Cash | -1.20B |
| Net Cash Per Share | -13.88 |
| Equity (Book Value) | 7.35B |
| Book Value Per Share | 72.45 |
| Working Capital | 1.38B |
Cash Flow
In the last 12 months, operating cash flow was -292.21 million and capital expenditures -173.67 million, giving a free cash flow of -465.88 million.
| Operating Cash Flow | -292.21M |
| Capital Expenditures | -173.67M |
| Depreciation & Amortization | 197.79M |
| Net Borrowing | -949.20M |
| Free Cash Flow | -465.88M |
| FCF Per Share | -5.37 |
Margins
Gross margin is 48.69%, with operating and profit margins of -6.76% and -12.35%.
| Gross Margin | 48.69% |
| Operating Margin | -6.76% |
| Pretax Margin | -5.94% |
| Profit Margin | -12.35% |
| EBITDA Margin | -2.45% |
| EBIT Margin | -6.76% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 2.10%.
| Dividend Per Share | 1.00 |
| Dividend Yield | 2.10% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.01% |
| Shareholder Yield | 2.17% |
| Earnings Yield | -14.19% |
| FCF Yield | -11.65% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 28, 2010. It was a forward split with a ratio of 1.16.
| Last Split Date | Jul 28, 2010 |
| Split Type | Forward |
| Split Ratio | 1.16 |
Scores
TPEX:4120 has an Altman Z-Score of 1.38 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.38 |
| Piotroski F-Score | 4 |